ethoxynonafluorobutane: used in HPLC
ID Source | ID |
---|---|
PubMed CID | 206000 |
SCHEMBL ID | 37807 |
MeSH ID | M0404070 |
Synonym |
---|
butane, 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluoro- |
1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane |
813458-04-7 |
nonafluorobutyl ethyl ether |
ethyl perfluorobutyl ether |
ethyl nonafluorobutyl ether |
AKOS007930484 |
ethoxynonafluorobutane |
520bw6fq5u , |
unii-520bw6fq5u |
163702-05-4 |
1-(ethoxy)nonafluorobutane |
butane, ethoxynonafluoro- |
FT-0676097 |
novec hfe 7200 |
ethyl perfluorobutyl ether [inci] |
(perfluorobutoxy)ethane |
SCHEMBL37807 |
c4f9oc2h5 |
hfe-7200 |
DTXSID0073118 |
mfcd01862062 |
ethyl nonafluorobutyl ether (mixture of isomers) |
J-010077 |
hfe-569sf2 (7200) |
1-ethoxy-nonafluorobutane |
butane,1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluoro- |
Q27260938 |
ethylnonafluorobutylether |
AS-75548 |
F87164 |
Excerpt | Reference | Relevance |
---|---|---|
"Ethoxynonafluorobutane (ENFB) has been used as a component of new biphasic solvent mixtures. " | ( Retention of fluorinated chiral selectors in biphasic fluorinated solvent systems and its application to the separation of enantiomers by countercurrent chromatography. Minguillón, C; Pérez, AM, 2010) | 1.8 |
Excerpt | Reference | Relevance |
---|---|---|
" Thus, completely substituting the main mobile phase component of a normal-phase LC solvent for an environmentally friendly, nonflammable fluorocarbon-ether as a safe and effective solvent must be thoroughly evaluated before it can be recommended for enantioselective separations with API-MS detection." | ( Evaluation of ethoxynonafluorobutane as a safe and environmentally friendly solvent for chiral normal-phase LC-atmospheric pressure chemical ionization/electrospray ionization-mass spectrometry. Armstrong, DW; Desai, M; Ding, J, 2005) | 0.69 |
Excerpt | Reference | Relevance |
---|---|---|
"The stereoselective determination of stereoisomers in biological samples provides vital information on stereospecific metabolism and pharmacokinetic profiles of the drugs." | ( Development and implementation of a stereoselective normal-phase liquid chromatography-tandem mass spectrometry method for the determination of intrinsic metabolic clearance in human liver microsomes. Caporuscio, C; D'Arienzo, C; Dai, J; Rose, A; Santella, J; Tymiak, AA; Wang-Iverson, DB; Witkusa, M; Zhang, Y, 2008) | 0.35 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.82) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |